Related references
Note: Only part of the references are listed.Cardiac actions of thyroid hormone metabolites
Grazia Rutigliano et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Nongenomic actions of thyroid hormone
Paul J. Davis et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
The thyroid hormone-αvβ3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation
E. Shinderman-Maman et al.
ONCOGENE (2016)
Synergistic active targeting of dually integrin αvβ3/CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies
Sanjun Shi et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Orally active αvβ3 integrin inhibitor MK-0429 reduces melanoma metastasis
Maureen Pickarski et al.
ONCOLOGY REPORTS (2015)
Thyroid hormone and anti-apoptosis in tumor cells
Hung-Yun Lin et al.
ONCOTARGET (2015)
Low thyroid hormone levels improve survival in murine model for ocular melanoma
Ido Didi Fabian et al.
ONCOTARGET (2015)
Cancer cell gene expression modulated from plasma membrane integrin αvβ3 by thyroid hormone and nanoparticulate tetrac
Paul J. Davis et al.
FRONTIERS IN ENDOCRINOLOGY (2015)
Relevance of the thyroid hormones-αvβ3 pathway in primary myeloma bone marrow cells and to bortezomib action
Keren Cohen et al.
LEUKEMIA & LYMPHOMA (2015)
Animal Eye Models for Uveal Melanoma
Jinfeng Cao et al.
OCULAR ONCOLOGY AND PATHOLOGY (2015)
Thyroid hormone regulates adhesion, migration and matrix metalloproteinase 9 activity via αvβ3 integrin in myeloma cells
Keren Cohen et al.
ONCOTARGET (2014)
Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective
Lars C. Moeller et al.
ENDOCRINE-RELATED CANCER (2013)
Multivalency of Non-Peptide Integrin αVβ3 Antagonist Slows Tumor Growth
Yoo-Shin Kim et al.
MOLECULAR PHARMACEUTICS (2013)
Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases
Felix Bock et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2013)
Adjunctive Input to the Nuclear Thyroid Hormone Receptor from the Cell Surface Receptor for the Hormone
Paul J. Davis et al.
THYROID (2013)
Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives
Kristina Buder et al.
CANCER MEDICINE (2013)
Combined QM/MM Study of Thyroid and Steroid Hormone Analogue Interactions with αvβ3 Integrin
Marek Freindorf et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Tetraiodothyroacetic acid-tagged liposomes for enhanced delivery of anticancer drug to tumor tissue via integrin receptor
Sangbin Lee et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Management of Pigmented Conjunctival Lesions
Patrick Oellers et al.
OCULAR SURFACE (2012)
Synergistic growth inhibition based on small-molecule p53 activation as treatment for intraocular melanoma
J. de Lange et al.
ONCOGENE (2012)
Membrane Receptor for Thyroid Hormone: Physiologic and Pharmacologic Implications
Paul J. Davis et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
Serum vascular endothelial growth factor (VEGF) levels correlate with number and location of micrometastases in a murine model of uveal melanoma
Michelle B. Crosby et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2011)
Thyroid Hormone Is a MAPK-Dependent Growth Factor for Human Myeloma Cells Acting via αvβ3 Integrin
Keren Cohen et al.
MOLECULAR CANCER RESEARCH (2011)
Uveal Melanoma: Trends in Incidence, Treatment, and Survival
Arun D. Singh et al.
OPHTHALMOLOGY (2011)
In Vivo High-Frequency, Contrast-Enhanced Ultrasonography of Uveal Melanoma in Mice: Imaging Features and Histopathologic Correlations
Qing Zhang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Molecular Aspects of Thyroid Hormone Actions
Sheue-Yann Cheng et al.
ENDOCRINE REVIEWS (2010)
In Aged Mice, Outgrowth of Intraocular Melanoma Depends on Proangiogenic M2-Type Macrophages
Long V. Ly et al.
JOURNAL OF IMMUNOLOGY (2010)
Thyroid hormones and cancer: clinical studies of hypothyroidism in oncology
Aleck H. Hercbergs et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2010)
Constitutive Overexpression of Pigment Epithelium-Derived Factor Inhibition of Ocular Melanoma Growth and Metastasis
Hua Yang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
Effectiveness of Treatments for Metastatic Uveal Melanoma
James J. Augsburger et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac)
Anna B. Glinskii et al.
CELL CYCLE (2009)
Survival in patients with uveal melanoma in Europe
Gianni Virgili et al.
ARCHIVES OF OPHTHALMOLOGY (2008)
Thyroid hormone stimulation of extracellular signal-regulated kinase and cell proliferation in human osteoblast-like cells is initiated at integrin αVβ3
A. Scarlett et al.
JOURNAL OF ENDOCRINOLOGY (2008)
Metabolic effects of thyroid hormone derivatives
Maria Moreno et al.
THYROID (2008)
被撤回的出版物: Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic (Retracted article. See vol. 195, 2023)
Hung-Yun Lin et al.
STEROIDS (2007)
Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells
Faith B. Davis et al.
CANCER RESEARCH (2006)
Combined immunologic and anti-angiogenic therapy reduces hepatic micrometastases in a murine ocular melanoma model
Hua Yang et al.
CURRENT EYE RESEARCH (2006)
Integrin αvβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis
JJ Bergh et al.
ENDOCRINOLOGY (2005)
Interferon α2b decreases hepatic micrometastasis in a murine model of ocular melanoma by activation of intrinsic hepatic natural killer cells
H Yang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor
HY Tang et al.
ENDOCRINOLOGY (2004)
A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of α1β1, α4β1 and α6β1 integrins
SR Elshaw et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2001)